Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0169 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_0169 |
| Peptide Name | APO-Ang2 |
| PEPTIDE SEQUENCE (1-letter) | TFFYGGSRGKRNNFKTEEY |
| PEPTIDE SEQUENCE (3-letter) | ThrPhePheTyrGlyGlySerArgGlyLysArgAsnAsnPheLysThrGluGluTyr |
| N-terminal modification | Conjugated with ASA drug |
| C-terminal modification | NA |
| Chemical modification | NA |
| Peptide Length | 19 |
| Conformation | Linear |
| Peptide Nature | NA |
| Source/Origin of peptide | NA |
| SMILES | NA |
| Cell Line | bEND cell line |
| In vitro CONCENTRATION | 2.5 microgram/ ml |
| In vitro METHOD | cellular uptake assay |
| In vitro RESULT | 22.9 % cellular uptake |
| ANIMAL MODEL | NA |
| In vivo CONCENTRATION | NA |
| In vivo MODE OF DELIVERY | NA |
| In vivo METHOD | NA |
| In vivo RESULT | NA |
| ACTION | NA |
| TRANSPORT TYPE | Transendocytosis |
| SUBCELLULAR LOCALISATION | NA |
| COMBINATION | NA |
| PHYSICAL CONDITION | Lysosomal disorder |
| RESPONSE | NA |
| RESULT | NA |
| LABEL | NA |
| PMID | 24573272 |